Abstract
Purpose: This research aimed to evaluate how anemia is handled in hemodialysis patients and identify risk factors. Methods: This study involved analyzing the current approach to managing anemia in a nephrology hospital, comparing it to KDOQI guidelines. It was conducted in a hospital specializing in the diagnosis and treatment of kidney diseases. In Tripoli, Libya, documents were randomly selected between October 2023 and May 2024. There were 89 patients receiving hemodialysis in total. Analysis of data was performed using SPSS Version 26. Results: Data on age distribution revealed that the largest age group consisted of individuals aged 56-65 years, comprising 39 patients (43.8%), closely trailed by the age range of 36-55 years, with 37 patients (41.6%). The average age was 53.56 years and there was a male to female ratio of 1.7:1. The results of the study showed that most patients (59.6%) had a mean Hgb value below 10, while 21.3% had a mean Hgb value between 10 and 10.9. Additionally, only ≥11 cases reported a percentage of 19.1% and also stated that the average Hgb value was 9.716. Conclusions: This study reveals that anemia isunsatisfactorily controlled in hemodialysis patients. ESA hyporesponsivness played a critical role in lowering hemoglobin levels in the current therapeuticstrategies used.